WebJul 29, 2013 · GERCOR - Multidisciplinary Oncology Cooperative Group: ClinicalTrials.gov Identifier: NCT01910610 Other Study ID Numbers: STRATEGIC-1 C12- 2 2013-001928-19 ( EudraCT Number ) First Posted: July 29, 2013 Key Record Dates: Last Update Posted: June 16, 2024 Last Verified: June 2024 NEONIPIGA is a French single-arm, multicenter academic phase II study promoted by GERCOR evaluating preoperative nivolumab and ipilimumab and postoperative nivolumab in patients with resectable dMMR/MSI-H gastric/GEJ adenocarcinoma. Patients were required to be at least 18 years of age or older (trial was amended in April 2024 to recommend 75 ...
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab …
WebAug 15, 2024 · phase II study promoted by GERCOR evaluating preoper-ative nivolumab and ipilimumab and postoperative nivo-lumab in patients with resectable dMMR/MSI-H … WebPurpose: This prospective pharmacokinetic (PK) ancillary study of the TEXCAN phase II GERCOR trial of patients with chemorefractory metastatic colorectal cancer and treated with regorafenib (REGO) investigated correlations between overall survival (OS) and concentrations (C) of REGO and its active metabolites, M-2 and M-5. Methods: 55 … goldair 4 burner gas hob
Nivolumab +/- Ipilimumab in Patients With Advanced, …
WebApr 5, 2024 · GERCOR - Multidisciplinary Oncology Cooperative Group: ClinicalTrials.gov Identifier: NCT05310643 Other Study ID Numbers: NIPIRESCUE G-113 : First Posted: … WebJun 2, 2024 · 4007 Background: The benefit of adapted physical activity (APA) on health-related quality of life (HRQoL) in Pts with advanced pancreatic ductal adenocarcinoma (aPDAC) treated by chemotherapy (CTx) has never been prospectively assessed. Methods: Pts with aPDAC and ECOG performance status (PS) 0–2 were randomized 1:1 to … WebAug 15, 2024 · phase II study promoted by GERCOR evaluating preoper-ative nivolumab and ipilimumab and postoperative nivo-lumab in patients with resectable dMMR/MSI-H gastric/ GEJ adenocarcinoma. Patients were required to be at least 18 years ofage or older (trial wasamended in April 2024to recommend 75 years and younger as an upper limit of … hb a\\u0026p show